Posted On: 08/16/2013 2:28:11 PM
Post# of 5066
Re: Blushingreen #2519
There is too talk of the IND application. It states that they are filing with the FDA in Q4 just like their timeline previously stated.
"Regen BioPharma is currently conducting toxicology experiments on its therapeutic approach, with anticipated FDA filing in the 4th Quarter of 2013."
"Regen BioPharma is currently conducting toxicology experiments on its therapeutic approach, with anticipated FDA filing in the 4th Quarter of 2013."
(0)
(0)
